Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 454 participants.
Also called NCT01692301
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 454 participants
- Sponsor
- Registry
-
NCT01692301 -
2012-002899-14
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Colombia, France, Germany, Greece, Italy, Japan, Russia, South Korea, Spain, Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT01692301. Randomized; double masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2015-04 (actual). Results posted on 2016-05-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension
- Condition
- Hypertension
- Intervention (Drug)
- LCZ696
- Intervention (Drug)
- Olmesartan
- Intervention (Drug)
- LCZ696 matching placebo
- Intervention (Drug)
- Olmesartan matching placebo
- Intervention (Drug)
- amlodipine
- Intervention (Drug)
- hydrochlorothiazide
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct01692301- Content hash
22165650e9c7536d675c02dec5e8b17c2b0a40ee83f4b6591362fb5aad929acd